Exhibit No. 1 |
Director/PDMR Shareholding dated 01 October 2014
|
Exhibit No. 2 |
Total Voting Rights dated 01 October 2014
|
Exhibit No. 3 |
Publication of Prospectus dated 01 October 2014
|
Exhibit No. 4 |
Block Listing dated 14 October 2014
|
Exhibit No. 5 |
Barclays passes EBA EU-wide stress test dated 27 October 2014
|
1. The allocation of Shares to PDMRs representing payment of the role based pay component ("Role Based Pay") of their fixed remuneration was notified to the Company on 30 September 2014. Role Based Pay is payable quarterly (but see note 1 below) and is subject to a holding period with restrictions lifting over five years (20% each year).
|
2. The reinvestment of the interim dividend for the quarter ending 30 June 2014 in Shares (the "Reinvestment 1") on behalf of PDMRs by an independent nominee, the Barclays Corporate Nominee Arrangement (previously Appleby Nominees), was notified to the Company on 30 September 2014.
|
3. The reinvestment of the interim dividend for the quarter ending 30 June 2014 in Shares by the trustee of the Barclays Group Sharepurchase Plan (the "Reinvestment 2"), an HM Revenue and Customs approved all employee share plan, was notified to the Company on 30 September 2014.
|
Directors
|
Shares held before the transaction
|
Date of transaction
|
Shares allocated to Director2
|
Price per Share allocated
|
Shares deducted to cover tax liabilities2 on Role Based Pay
|
Balance of Shares held
|
Directors
|
A
|
B
|
C
|
A+B-C
|
||
A Jenkins1
- Role Based Pay
|
4,052,629
|
30.09.14 |
103,852
|
£2.2869
|
48,811
|
4,107,670
|
T Morzaria1
- Role Based Pay
- Reinvestment 1
|
349,324
|
30.09.14
30.09.14
|
81,988
1,069
|
£2.2869
£2.3100
|
38,535
-
|
393,846
|
Other PDMRs
|
Date of transaction
|
Shares allocated to PDMR2
|
Price per Share allocated
|
Shares deducted to cover tax liabilities2 on Role Based Pay
|
R le Blanc
- Role Based Pay
- Reinvestment 1
- Reinvestment 2
|
30.09.14
30.09.14
30.09.14
|
131,181
2,162
1
|
£2.2869
£2.3100
£2.2902
|
61,656
-
-
|
I McDermott Brown
- Role Based Pay
- Reinvestment 1
|
30.09.14
30.09.14
|
21,863
214
|
£2.2869
£2.3100
|
10,276
-
|
B Hoyt
- Role Based Pay
- Reinvestment 1
|
30.09.14
30.09.14
|
65,590
694
|
£2.2869
£2.3100
|
30,828
-
|
V Soranno Keating
- Role Based Pay
- Reinvestment 1
|
30.09.14
30.09.14
|
65,590
1,569
|
£2.2869
£2.3100
|
30,828
-
|
T King
- Role Based Pay
- Reinvestment 1
|
30.09.14
30.09.14
|
262,995
2,921
|
£2.2869
£2.3100
|
135,627
-
|
M Roemer
- Role Based Pay
- Reinvestment 1
|
30.09.14
30.09.14
|
49,193
543
|
£2.2869
£2.3100
|
23,121
-
|
A Vaswani
- Role Based Pay
- Reinvestment 1
- Reinvestment 2
|
30.09.14
30.09.14
30.09.14
|
76,552
678
20
|
£2.2869
£2.3100
£2.2902
|
35,966
-
-
|
M Harte
- Role Based Pay
|
30.09.14
|
57,035
|
£2.2869
|
26,807 |
1 Shares allocated to the PDMRs represent the role based pay component of their fixed remuneration for the three months to 30 September 2014.
|
2 Tax liabilities on the Shares provided were met in cash and the number of Shares actually received by each individual was reduced by an amount equivalent in value as required to meet those tax liabilities.
|
Investor Relations
|
Media Relations
|
Charlie Rozes
|
Giles Croot
|
+44 (0) 207 116 5752
|
+44 (0) 207 116 4755
|
Employee Share Scheme
|
Number Shares
|
Barclays Group Share Incentive Plan
|
20,000,000
|
Barclays Group SAYE Share Option Scheme
|
25,000,000
|
Investor Relations
|
Media Relations
|
Charlie Rozes
|
Giles Croot
|
+44 (0) 20 7116 5752
|
+44 (0) 20 7116 6132
|